Orbus Therapeutics

About:

Orbus Therapeutics is dedicated to developing products that treat rare diseases.

Website: http://www.orbustherapeutics.com/

Top Investors: Adams Street Partners, Longitude Capital, Agent Capital, H.I.G. BioHealth Partners, Ernest Mario

Description:

They at Orbus are committed to bringing innovative products to the extremely underserved patients affected by rare diseases. They are focused and passionate about bringing a more positive outcome to patients facing life-threatening or significantly life-altering diseases. Currently, Orbus Therapeutics is working to develop and commercialize eflornithine in North America. The company was founded in 2012 and is headquartered in Palo Alto, California.